Your browser doesn't support javascript.
loading
Efficacy of Occipital Nerve Stimulation to Treat Refractory Occipital Headaches: A Single-Institution Study of 60 Patients.
Raoul, Sylvie; Nguyen, Jean Michel; Kuhn, Emmanuelle; de Chauvigny, Edwige; Lejczak, Sarah; Nguyen, Jean-Paul; Nizard, Julien.
Afiliação
  • Raoul S; Neurosurgery Department, UIC22, University Hospital, Nantes, France.
  • Nguyen JM; Multidisciplinary Pain, Palliative and Supportive Care Department, UIC 22 and Therapeutics Laboratory (EA3826), University Hospital, Nantes, France.
  • Kuhn E; Biostatistics Department and UMR INSERM 1246, University Hospital, Nantes, France.
  • de Chauvigny E; Multidisciplinary Pain, Palliative and Supportive Care Department, UIC 22 and Therapeutics Laboratory (EA3826), University Hospital, Nantes, France.
  • Lejczak S; Multidisciplinary Pain, Palliative and Supportive Care Department, UIC 22 and Therapeutics Laboratory (EA3826), University Hospital, Nantes, France.
  • Nguyen JP; Multidisciplinary Pain, Palliative and Supportive Care Department, UIC 22 and Therapeutics Laboratory (EA3826), University Hospital, Nantes, France.
  • Nizard J; Neurosurgery Department, UIC22, University Hospital, Nantes, France.
Neuromodulation ; 23(6): 789-795, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32725745
ABSTRACT

BACKGROUND:

Occipital nerve stimulation (ONS) is shown to be effective in treating various forms of headache. Most studies describe the treatment of occipital neuralgia (ON), but in many patients, the clinical description could also correspond to cervicogenic headache (CGH) or occipital migraine (OM). These different entities (ON, CGH, and OM) may be grouped together under the term occipital headaches.

OBJECTIVE:

To assess the efficacy of ONS to treat occipital headaches in a large series of patients with a long-term follow-up. MATERIALS AND

METHODS:

We performed a retrospective review of data on 60 patients with intractable occipital headaches treated with occipital nerve stimulation (ONS), who were referred to our center between October 2008 and October 2014. Details of pain evaluation, location, duration, cause and previous treatment were analyzed. Evaluations included the visual analog scale (VAS), the number of headache days per month (NHD), and the Medication Quantification Scale (MQS). Trials with transcutaneous electrical nerve stimulation (TENS-ONS) were performed and served as a guide for surgery indication (see Patients and Method section).

RESULTS:

After one year of ONS, mean VAS had decreased from 8.4/10 to 2.8/10 (72.2% reduction [p < 0.001]), and 76% of patients had at least a 50% decrease in mean VAS score. The mean MQS score decreased from 18 to 8.8, corresponding to a reduction of pain medication by an average of 50%. Adverse events concerned 12 patients (20%). Six patients presented with electrode displacement or fracture (10%) and six patients presented with cases of infection (10%) associated with the pulse generator.

CONCLUSIONS:

The results of this large series confirm that ONS is an effective treatment option for patients with intractable occipital headaches, but the frequency of complications remains quite high and must be taken into account in the surgical decision.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia por Estimulação Elétrica / Transtornos da Cefaleia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia por Estimulação Elétrica / Transtornos da Cefaleia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article